Home › Chronic-Phase Myeloid Leukemia › Oregon
Chronic-Phase Myeloid Leukemia clinical trials in Oregon
4 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in Oregon.
Cities in Oregon
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Willamette Valley Cancer Institute and Research Center, Eugene
- Oregon Health & Science University, Portland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06163430Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1139, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Oregon Oncology Specialists Salem, Salem
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Jul 20, 2026 · NCT07091019A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Oregon Health & Science University-Knight Cardiovascular Institute, Portland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT05304377From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.